SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Hughes SL, Dunlop D. The prevalence and impact of arthritis in older persons. Arthritis Care Res 1995; 8: 25764.
  • 2
    Health Canada. Arthritis in Canada: an ongoing challenge. Ottawa: Health Canada; 2003.
  • 3
    Hootman J, Bolen J, Helmick C, Langmaid G. Prevalence of doctor-diagnosed arthritis and arthritis-attributable activity limitation: United States, 2003-2005 [published errata appear in MMWR Morb Mortal Wkly Rep 2006;55:1129 and MMWR Morb Mortal Wkly Rep 2007;56:55]. MMWR Morb Mortal Wkly Rep 2006; 55: 108992.
  • 4
    Ganz DA, Chang JT, Roth CP, Guan M, Kamberg CJ, Niu F, et al. Quality of osteoarthritis care for community-dwelling older adults. Arthritis Rheum 2006; 55: 2417.
  • 5
    Glazier RH, Badley EM, Wright JG, Coyte PC, Williams JI, Harvey B, et al. Patient and provider factors related to comprehensive arthritis care in a community setting in Ontario, Canada. J Rheumatol 2003; 30: 184650.
  • 6
    Peat G, McCarney R, Croft P. Knee pain and osteoarthritis in older adults: a review of community burden and current use of primary health care. Ann Rheum Dis 2001; 60: 917.
  • 7
    Tsuyuki RT, Johnson JA, Teo KK, Simpson SH, Ackman ML, Biggs RS, et al. A randomized trail of the effect of community pharmacist intervention on cholesterol risk management: the Study of Cardiovascular Risk Intervention by Pharmacists (SCRIP). Arch Intern Med 2002; 162: 114955.
  • 8
    Rothman RL, Malone R, Bryant B, Shintani AK, Crigler B, Dewalt DA, et al. A randomized trial of a primary care-based disease management program to improve cardiovascular risk factors and glycated hemoglobin levels in patients with diabetes. Am J Med 2005; 118: 27684.
  • 9
    Law AV, Shapiro K. Impact of a community pharmacist-directed clinic in improving screening and awareness of osteoporosis. J Eval Clin Pract 2005; 11: 24755.
  • 10
    Leung WY, So WY, Tong PC, Chan NN, Chan JC. Effects of structured care by a pharmacist-diabetes specialist team in patients with type 2 diabetic nephropathy. Am J Med 2005; 118: 1414. e21–7.
  • 11
    Tsuyuki RT, Olson KL, Dubyk AM, Schindel TJ, Johnson JA. Effect of community pharmacist intervention on cholesterol levels in patients at high risk of cardiovascular events: the Second Study of Cardiovascular Risk Intervention by Pharmacists (SCRIP-plus). Am J Med 2004; 116: 1303.
  • 12
    Leal S, Glover JJ, Herrier RN, Felix A. Improving quality of care in diabetes through a comprehensive pharmacist-based disease management program. Diabetes Care 2004; 27: 29834.
  • 13
    Ernst ME, Iyer SS, Doucette WR. Drug-related problems and quality of life in arthritis and low back pain sufferers. Value Health 2003; 6: 518.
  • 14
    Mazzuca SA, Page MC, Meldrum RD, Brandt KD, Petty- Saphon S. Pilot study of the effects of a heat-retaining knee sleeve on joint pain, stiffness, and function in patients with knee osteoarthritis. Arthritis Rheum 2004; 51: 71621.
  • 15
    Bellamy N. WOMAC: a 20-year experiential review of a patient-centered self-reported health status questionnaire. J Rheumatol 2002; 29: 24736.
  • 16
    Kosinski M, Keller SD, Ware JE Jr, Hatoum HT, Kong SX. The SF-36 Health Survey as a generic outcome measure in clinical trials of patients with osteoarthritis and rheumatoid arthritis: relative validity of scales in relation to clinical measures of arthritis severity. Med Care 1999; 37 Suppl 5: MS2339.
  • 17
    Altman R, Asch E, Bloch D, Bole G, Borenstein D, Brandt K, et al. Development of criteria for the classification and reporting of osteoarthritis: classification of osteoarthritis of the knee. Arthritis Rheum 1986; 29: 103949.
  • 18
    Cibere J, Bellamy N, Thorne A, Esdaile JM, McGorm KJ, Chalmers A, et al. Reliability of the knee examination in osteoarthritis: effect of standardization. Arthritis Rheum 2004; 50: 45868.
  • 19
    Kellgren JH, Lawrence JS. Radiological assessment of osteo-arthrosis. Ann Rheum Dis 1957; 16: 494501.
  • 20
    Shrout PE, Fleiss JL. Intraclass correlations: uses in assessing rater reliability. Psychol Bull 1979; 86: 4208.
  • 21
    Knapp KK, Paavola FG, Maine LL, Sorofman B, Politzer RM. Availability of primary care providers and pharmacists in the United States. J Am Pharm Assoc 1999; 39: 12735.
  • 22
    Zillich AJ, Sutherland JM, Kumbera PA, Carter BL. Hypertension outcomes through blood pressure monitoring and evaluation by pharmacists (HOME Study). J Gen Intern Med 2005; 20: 10916.
  • 23
    Hay EM, Foster NE, Thomas E, Peat G, Phelan M, Yates HE, et al. Effectiveness of a community physiotherapy and enhanced pharmacy review for knee pain in people aged over 55 presenting to primary care: pragmatic randomized trial. BMJ 2006; 333: 995. E-pub 2006 Oct 20.
  • 24
    Cibere J, Trithart S, Kopec JA, Thorne A, Zhang H, Singer J, et al. Pre-radiographic knee osteoarthritis is common in people with knee pain: results from a population-based study [abstract]. Arthritis Rheum 2005; 52 Suppl 9: S509.
  • 25
    Focht BC, Rejeski WJ, Ambrosius WT, Katula JA, Messier SP. Exercise, self-efficacy, and mobility performance in overweight and obese older adults with knee osteoarthritis. Arthritis Rheum 2005; 53: 65965.
  • 26
    Miller GD, Nicklas BJ, Davis C, Loeser RF, Lenchik L, Messier SP. Intensive weight loss program improves physical function in older obese adults with knee osteoarthritis. Obesity (Silver Spring) 2006; 14: 121930.
  • 27
    Christensen R, Bartels EM, Astrup A, Bliddal H. Effect of weight reduction in obese patients diagnosed with knee osteoarthritis: a systematic review and meta-analysis. Ann Rheum Dis 2007; 66: 4339.
  • 28
    Martin K, Fontaine KR, Nicklas BJ, Dennis KE, Goldberg AP, Hochberg MC. Weight loss and exercise walking reduce pain and improve physical functioning in overweight postmenopausal women with knee osteoarthritis. J Clin Rheumatol 2001; 7: 21923.
  • 29
    Brandt KD, Mazzuca SA. Lessons learned from nine clinical trials of disease-modifying osteoarthritis drugs [review]. Arthritis Rheum 2005; 52: 334959.